Advertisement
U.S. Markets closed

Ocular Therapeutix, Inc. (0OT.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
10.28+0.06 (+0.64%)
At close: 03:57PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.63B
Enterprise Value 1.28B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)21.95
Price/Book (mrq)4.57
Enterprise Value/Revenue 22.62
Enterprise Value/EBITDA -5.96

Trading Information

Stock Price History

Beta (5Y Monthly) 1.28
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 310.95
52 Week Low 31.88
50-Day Moving Average 38.04
200-Day Moving Average 36.77

Share Statistics

Avg Vol (3 month) 399
Avg Vol (10 day) 3505
Shares Outstanding 5155.92M
Implied Shares Outstanding 6N/A
Float 8118.91M
% Held by Insiders 11.19%
% Held by Institutions 189.38%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -226.46%
Operating Margin (ttm)-265.13%

Management Effectiveness

Return on Assets (ttm)-22.37%
Return on Equity (ttm)-72.67%

Income Statement

Revenue (ttm)61.1M
Revenue Per Share (ttm)0.53
Quarterly Revenue Growth (yoy)8.30%
Gross Profit (ttm)N/A
EBITDA -110.75M
Net Income Avi to Common (ttm)-138.36M
Diluted EPS (ttm)-1.01
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)459.69M
Total Cash Per Share (mrq)2.95
Total Debt (mrq)74.89M
Total Debt/Equity (mrq)19.83
Current Ratio (mrq)16.64
Book Value Per Share (mrq)2.43

Cash Flow Statement

Operating Cash Flow (ttm)-88.88M
Levered Free Cash Flow (ttm)-55.72M